Literature DB >> 10584463

The use of mirtazapine in a patient with chronic pain.

G E Brannon1, K D Stone.   

Abstract

Antidepressant drugs that act on serotonin and noradrenergic systems may be analgesic. The newer antidepressant mirtazapine (Remeron) has activity on noradrenergic and serotonergic transmission and is approved for the treatment of a Major Depressive Disorder. This paper describes a case that suggests that mirtazapine may also be useful in the treatment of chronic pain.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10584463     DOI： 10.1016/s0885-3924(99)00098-6

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


  3 in total

Review 1.  Antidepressants in the management of cancer pain.

Authors:  T A Mays
Journal:  Curr Pain Headache Rep       Date:  2001-06

Review 2.  The psychopharmacologic treatment of depression and anxiety in the context of chronic pain.

Authors:  Sunil Verma; Rollin M Gallagher
Journal:  Curr Pain Headache Rep       Date:  2002-02

3.  Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with morphine and naloxone in mice.

Authors:  Pranav Sikka; Sadhna Kaushik; Gyanendra Kumar; Seema Kapoor; V K Bindra; K K Saxena
Journal:  J Pharm Bioallied Sci       Date:  2011-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.